1. Home
  2. ALT vs GUT Comparison

ALT vs GUT Comparison

Compare ALT & GUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • GUT
  • Stock Information
  • Founded
  • ALT 1997
  • GUT 1999
  • Country
  • ALT United States
  • GUT United States
  • Employees
  • ALT N/A
  • GUT N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • GUT Trusts Except Educational Religious and Charitable
  • Sector
  • ALT Health Care
  • GUT Finance
  • Exchange
  • ALT Nasdaq
  • GUT Nasdaq
  • Market Cap
  • ALT 472.3M
  • GUT 475.6M
  • IPO Year
  • ALT N/A
  • GUT N/A
  • Fundamental
  • Price
  • ALT $5.40
  • GUT $5.47
  • Analyst Decision
  • ALT Strong Buy
  • GUT
  • Analyst Count
  • ALT 7
  • GUT 0
  • Target Price
  • ALT $21.00
  • GUT N/A
  • AVG Volume (30 Days)
  • ALT 2.5M
  • GUT 176.3K
  • Earning Date
  • ALT 05-13-2025
  • GUT 01-01-0001
  • Dividend Yield
  • ALT N/A
  • GUT 10.93%
  • EPS Growth
  • ALT N/A
  • GUT N/A
  • EPS
  • ALT N/A
  • GUT N/A
  • Revenue
  • ALT $20,000.00
  • GUT N/A
  • Revenue This Year
  • ALT $4,108.32
  • GUT N/A
  • Revenue Next Year
  • ALT $3,900.06
  • GUT N/A
  • P/E Ratio
  • ALT N/A
  • GUT N/A
  • Revenue Growth
  • ALT N/A
  • GUT N/A
  • 52 Week Low
  • ALT $3.55
  • GUT $4.60
  • 52 Week High
  • ALT $11.16
  • GUT $7.38
  • Technical
  • Relative Strength Index (RSI)
  • ALT 52.71
  • GUT 62.61
  • Support Level
  • ALT $5.38
  • GUT $5.37
  • Resistance Level
  • ALT $5.81
  • GUT $5.48
  • Average True Range (ATR)
  • ALT 0.35
  • GUT 0.06
  • MACD
  • ALT -0.03
  • GUT 0.01
  • Stochastic Oscillator
  • ALT 34.18
  • GUT 85.00

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About GUT Gabelli Utility Trust (The)

Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.

Share on Social Networks: